Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ginkgo Diterpene Lactone Meglumine + Aspirin in Acute Ischemic Stroke
NCT03219645Phase 3Unknown
- Sponsor
- Renji Hospital
- Start
- Jul 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Ginkgo diterpene lactone meglumine in ischemic stroke, sponsored by Renji Hospital. Status: unknown.
02
Drugs
Ginkgo diterpene lactone meglumine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03219645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219645.